Survey data shows individuals are not informed on how COVID-19 could affect their conditions.
Jeremy Edwards
Advertisement
Articles by Jeremy Edwards
87% of people surveyed said they had no concerns about a decentralized approach to clinical trials.
Advertisement
Latest Updated Articles
- Recent Data Shows Positive Attitudes for Decentralized Trials in Rare Disease Patients
Published: November 13th 2020 | Updated:
Rare Disease Patients Overlooked During COVIDPublished: June 7th 2021 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Clinical Trials in 2026: Platformization, AI Fluency, and the Redrawing of the Value Chain
2
ACT Brief: Community Sites Compete on Readiness, COA Licensing Bottlenecks Slow Start-Up, and AI’s Foundations in Pharmacovigilance
3
Moving Beyond Historical Site Data to Real-Time Patient Insight
4
The Challenges of Buying Blind: Why Providing the Clinical Outcome Assessment Measure Prior to License Execution Would Significantly Benefit Clinical Trial Set-Up
5